Approximately three years ago, this journal published a review on the
clinical and molecular analysis of mitochondrial encephalomyopathies,
with emphasis on defects in mitochondrial DNA (mtDNA). At that time, a
pproximately 30 point mutations associated with a variety of maternall
y-inherited (or rarely, sporadic) disorders had been described. Since
that time, almost twenty new pathogenic mtDNA point mutations have bee
n described, and the pace of discovery of such mutations shows no sign
s of abating. This accumulating body of data has begun to reveal some
patterns that may be relevant to pathogenesis.